Farther Finance Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.5K | Buy |
638
+5
| +0.8% | +$568 | ﹤0.01% | 1928 |
|
|
2025
Q1 | $66.4K | Sell |
633
-133
| -17% | -$13.9K | ﹤0.01% | 1752 |
|
|
2024
Q4 | $82.1K | Sell |
766
-10
| -1% | -$1.07K | ﹤0.01% | 1401 |
|
|
2024
Q3 | $77.7K | Buy |
776
+74
| +11% | +$7.41K | ﹤0.01% | 1424 |
|
|
2024
Q2 | $59.6K | Buy |
702
+625
| +812% | +$53K | ﹤0.01% | 1348 |
|
|
2024
Q1 | $5.67K | Sell |
77
-5
| -6% | -$368 | ﹤0.01% | 2009 |
|
|
2023
Q4 | $5.86K | Buy |
+82
| New | +$5.86K | ﹤0.01% | 1885 |
|